Contacts

Shane Gleghorn

Associé

Read More

Andrew Edge

Associé

Read More

Adrian Toutoungi

Associé

Read More

Fiona Coady

Associé

Read More
Contacts

Shane Gleghorn

Associé

Read More

Andrew Edge

Associé

Read More

Adrian Toutoungi

Associé

Read More

Fiona Coady

Associé

Read More

21 septembre 2023

Further recognition for our market-leading work in the life sciences sector

We have won Life Sciences Team of the Year at the Legal Business Awards 2023 for advising on three simultaneous transformational transactions for AIM-listed Shield Therapeutics plc.

Led by partners Andrew Edge, Adrian Toutoungi and Fiona Coady, supported by associates Samuel Curme, Victoria Smaill, Charlie Adams, Kate Bowden, Alexander Swayne, and trainee Joe Burton, the transactions included a three-pronged equity fundraising, the extension of a convertible debt facility with Austrian headquartered international pharmaceutical company AOP Health International, and an exclusive, multi-year transformational collaboration agreement with global healthcare company Viatris, Inc. This transaction enabled Shield to accelerate commercialisation of its iron deficiency product, Accrufer®, in the United States and total prescriptions for the second quarter of 2023 were 173% higher than those for the corresponding period in 2022.

Lucy Bailey, General Counsel of Shield Therapeutics said: "The Taylor Wessing lawyers were an integral part of the Shield team, working alongside myself and the Shield senior management and Board. The combination of deep life sciences sector experience with equity capital markets and debt financing expertise of the highest calibre was essential to successful delivery of their service, but what stood out for me was the judgement and advice they offered."

Greg Madison, CEO of Shield Therapeutics plc said: "We are very grateful to the Taylor Wessing team for their continued support and involvement throughout this complex transaction. The collaborative approach from the Taylor Wessing Corporate, Commercial and Finance teams and in-depth expertise from all practices was simply outstanding."

Commenting on this award, UK Managing Partner Shane Gleghorn said: "We are delighted with this latest recognition for our Life Sciences and Healthcare Sector group which demonstrates the power of our strategic focus and continuous investment in talent that enabled us to work together with Shield Therapeutics to successfully achieve their objectives.”

This award follows our recognition as at Law.com's 2022 British Legal Awards where we were named Life Sciences Team of the Year for advising Apollo Therapeutics, a biopharmaceutical company progressing transformative treatments based on breakthrough discoveries, on its $145 million series A financing. Taylor Wessing has also advised in relation to Apollo's recent $226 million Series C financing.

Additional plaudits at the Legal Business Awards included being highly commended in the category of Real Estate Team of the Year, as well as being on the shortlist for Legal Technology Team of the Year.  

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Careers

Announcing 14 new partners in the UK and Germany

2 mai 2023

par Shane Gleghorn

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Shield Therapeutics enters transformational collaboration agreement with Viatris and raises debt and equity finance

6 janvier 2023

par Andrew Edge

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

14 juillet 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus